News Conference News TCT 2024 EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS L.A. McKeown October 28, 2024
News Conference News TCT 2024 Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT Michael O'Riordan October 27, 2024
News Conference News TCT 2024 LAAO Outcomes Similar Regardless of Operator’s Specialty Todd Neale October 27, 2024
News Conference News TCT 2023 Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials Michael O'Riordan October 24, 2023
News Conference News TCT 2021 More DAPT Duration Data, More Calls to Tailor to Individual Patients Shelley Wood November 05, 2021
News Conference News TCT 2021 More Complications With Plug Closure After TAVI: CHOICE-CLOSURE Michael O'Riordan November 05, 2021
News Conference News TCT 2021 NSTEMI Patients With CKD See Better Outcomes With Invasive Strategy L.A. McKeown October 22, 2021
News Conference News TCT 2020 EXAMINATION Surprise: Few Late Event Gaps Between DES and BMS in STEMI L.A. McKeown October 22, 2020
News Conference News TCT 2019 ‘Spooky’ Signal Still Haunts Paclitaxel DCBs in PAD, but Updated Analysis Reassures L.A. McKeown September 28, 2019
News Conference News TCT 2017 Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery Yael L. Maxwell October 31, 2017
News Opinion Editor's Corner TCT 2016 My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway Shelley Wood November 07, 2016
News Conference News TCT 2016 EXCEL and NOBLE: Opposing Results Pose Quandary for PCI/CABG Choice in Left Main Disease Michael O'Riordan October 31, 2016